- Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Endocrinology Diabetes & Metabolism · 2025
- Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis
British Journal of Pharmacology · 2025
- Semaglutide and Exercise Function in Obesity-Related HFpEF
JACC Heart Failure · 2025
- Bridging the Gap to Waitlist Activation: Semaglutide's Weight Loss Efficacy and Safety in Patients With Obesity on Dialysis Seeking Kidney Transplantation
Clinical Transplantation · 2025
- The impact of semaglutide on peri‐operative cardiovascular outcomes in diabetes
Diabetes Obesity and Metabolism · 2025
- Impact of Semaglutide 2.4 mg on Healthcare Resource Utilization and Medical Costs in Patients With Heart Failure in the United States (SHINE-HF)
Clinical Therapeutics · 2025
- Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial
Reproductive Biology and Endocrinology · 2025
- Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of <scp>SUSTAIN</scp> 6 and <scp>PIONEER</scp> 6
Diabetes Obesity and Metabolism · 2025
- Cardiovascular outcomes and safety of semaglutide in non-overweight populations with type 2 diabetes: a comparison with dipeptidyl peptidase 4 inhibitors
European Heart Journal - Quality of Care and Clinical Outcomes · 2025
- GLP-1RA versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: An updated meta-analysis of randomized controlled trials
International Journal of Cardiology · 2025
- Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease
Nephrology Dialysis Transplantation · 2025
- The global clinical trial landscape for non-alcoholic fatty liver disease (NAFLD): current status and future prospects
International Journal of Surgery · 2025
- Long‐Term Impact of GLP‐1 Receptor Agonists on AF Recurrence After Ablation in Obese Patients
Journal of Cardiovascular Electrophysiology · 2025
- Finerenone and semaglutide: Role in heart failure with reduced ejection fraction
World Journal of Cardiology · 2025
- Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
British Journal of Clinical Pharmacology · 2025
- Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trial
American Heart Journal · 2025
- Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials
European Journal of Preventive Cardiology · 2025
- Pulmonary Artery Pressure Trajectories in Heart Failure Patients Treated with GLP-1 Receptor Agonists
ESC Heart Failure · 2025
- Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
Cardiovascular Diabetology · 2025
- The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes
Advances in Therapy · 2025
- Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
Diabetes Care · 2025
- Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue
Molecular Metabolism · 2025
- Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide
Medicina · 2025
- Cardioprotective Effects of Semaglutide on Isolated Human Ventricular Myocardium
European Journal of Heart Failure · 2025
- Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study
Diabetes Obesity and Metabolism · 2025
- Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond
Current Opinion in Nephrology & Hypertension · 2025
- The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)
Cardiovascular Diabetology · 2025
- Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy
Clinical Obesity · 2025
- Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome
International Journal of Cardiology · 2025
- Factors Associated With Semaglutide Initiation Among Adults With Obesity
JAMA Network Open · 2025
- Semaglutide protects against diabetes‐associated cardiac inflammation via Sirt3‐dependent RKIP pathway
British Journal of Pharmacology · 2024
- Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease
Arteriosclerosis Thrombosis and Vascular Biology · 2024
- Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2
Drug Design Development and Therapy · 2024
- Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with Myocardial Infarction
Drug Design Development and Therapy · 2024
- Semaglutide Normalizes Increased Cardiomyocyte Calcium Transients in a Rat Model of High Fat Diet-Induced Obesity
ESC Heart Failure · 2024
- Impact of semaglutide on weight and functional outcomes among obese heart failure patients: a propensity scores matching analysis
BMC Cardiovascular Disorders · 2024
- Lower Risk of Postoperative Complications and Rotator Cuff Retear Associated With Semaglutide Use in Patients with Type II Diabetes Mellitus Undergoing Arthroscopic Rotator Cuff Repair
Arthroscopy The Journal of Arthroscopic and Related Surgery · 2024
- GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
Heart Failure Reviews · 2024
- Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open‐label study
Diabetes Obesity and Metabolism · 2024
- Comparison of cardiovascular outcomes in patients with diabetes treated with tirzepatide versus semaglutide: a multi-institutional analysis
European Heart Journal · 2024
- Association of semaglutide treatment with coronary artery inflammation in type 2 diabetes mellitus patients: a retrospective study based on pericoronary adipose tissue attenuation
Cardiovascular Diabetology · 2024
- Semaglutide and blood pressure: an individual patient data meta-analysis
European Heart Journal · 2024
- Semaglutide: an emerging treatment option for patients with obesity related HFpEF
Journal of the Pakistan Medical Association · 2024
- Glucagon‐like peptide‐1 receptor agonist semaglutide reduces atrial fibrillation incidence: A systematic review and meta‐analysis
European Journal of Clinical Investigation · 2024
- Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
The Lancet · 2024
- Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial
Diabetes Obesity and Metabolism · 2024
- Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network
Cardiovascular Diabetology · 2024
- Semaglutide alleviates early brain injury following subarachnoid hemorrhage by suppressing ferroptosis and neuroinflammation via SIRT1 pathway
American Journal of Translational Research · 2024
- Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few
European Heart Journal · 2023
- Obesity, heart failure with preserved ejection fraction, and the role of glucagon‐like peptide‐1 receptor agonists
ESC Heart Failure · 2023